[1] JEON S K, LEE J M, JPP I, et al. Prospective evaluation of hepatic gteatosis using ultrasound attenuation imaging in patients with chronic liver disease with magnetic resonance imaging proton density fat fraction as the reference standard[J]. Ultrasound Med Biol, 2019, 45(6):1407-1416. [2] CUNHA G M, THAI T T, HAMILTON G, et al. Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity[J]. Abdom Radiol (NY), 2020, 45(3):661-671. [3] FRIEDMAN S L, NEUSCHWANDER-TETRI B A, RINELLA M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24(7):908-922. [4] KÜHN J P, MEFFERT P, HESKE C, et al. Prevalence of fatty liver disease and hepatic iron overload in a northeastern German population by using quantitative MR imaging[J]. Radiology, 2017, 284(3):706-716. [5] IDILMAN I S, KESKIN O, CELIK A, et al. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease[J]. Acta Radiol, 2015, 57(3):271-278. [6] TADA T, KUMADA T, TOYODA H, et al. Utility of attenuation coefficient measurement using an ultrasound-guided attenuation parameter for evaluation of hepatic steatosis:comparison with MRI-determined proton density fat fraction[J]. Am J Roentgenol, 2019, 212(2):332-341. [7] CORRIAS G, KREBS S, ESKREIS-WINKLER S, et al. MRI liver fat quantification in an oncologic population:the added value of complex chemical shift-encoded MRI[J]. Clin Imaging, 2018, 52:193-199. [8] TANG A, TAN J, SUN M, et al. Nonalcoholic fatty liver disease:MR imaging of liver proton density fat fraction to assess hepatic steatosis[J]. Radiology, 2013, 267(2):422-431. [9] IDILMAN I S, ANIKTAR H, IDILMAN R, et al. Hepatic steatosis:quantification by proton density fat fraction with MR imaging versus liver biopsy[J]. Radiology, 2013, 267(3):767-775. [10] YE J, WU Y, LI F, et al. Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity:assessment using magnetic resonance imaging-derived proton density fat fraction[J]. Therapeut Adv Gastroenterol, 2019. DOI:10.1177/1756284819879047. [11] LEE S J, KIM S U. Noninvasive monitoring of hepatic steatosis:controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(6):523-530. [12] MCHENRY S, SHARMA Y, TIRATH A, et al. Crohn's disease is associated with an increased prevalence of nonalcoholic fatty liver disease:a cross-sectional study using magnetic resonance proton density fat fraction mapping[J]. Clin Gastroenterol Hepatol, 2019, 17(13):2816-2818. [13] GU J L, LIU S S, DU S X, et al. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease:a meta-analysis[J]. Eur Radiol, 2019, 29(7):3564-3573. [14] GUO Z, BLAKE G M, LI K, et al. Liver fat content measurement with quantitative CT validated against MRI proton density fat fraction:a prospective study of 400 healthy volunteers[J]. Radiology, 2020, 294(1):89-97. [15] FERRAIOLI G, MAIOCCHI L, RACITI M V, et al. Detection of liver steatosis with a novel ultrasound-based technique:a pilot study using MRI-derived proton density fat fraction as the gold standard[J]. Clin Transl Gastroenterol, 2019, 10(10):e00081. [16] LEITÃO H S, PAULINO C, RODRIGUES D, et al. MR fat fraction mapping[J]. Acad Radiol, 2013, 20(8):957-961. [17] IDILMAN I S, TUZUN A, SAVAS B, et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease[J].Abdom Imaging, 2015, 40(6):1512-1519. [18] DI MARTINO M, PACIFICO L, BEZZI M, et al. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents[J]. World J Gastroenterol, 2016, 22(39):8812-8819. [19] NOUREDDIN M, LAM J, PETERSON M R, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials[J]. Hepatology, 2013, 58(6):1930-1940. [20] TANG A, DESAI A, HAMILTON G, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease[J]. Radiology, 2015, 274(2):416-425. [21] 周懂晶,黄丽霞,刘玉品,等. 3.0 T磁共振IDEAL-IQ技术定量评估脂肪肝的价值[J]. 中华生物医学工程杂志. 2017, 23(1):55-58. [22] COLGAN T J, VAN PAY A J, SHARMA S D, et al. Diurnal variation of proton density fat fraction in the liver using quantitative chemical shift encoded MRI[J]. J Magn Reson Imaging, 2020, 51(2):407-414. [23] 洪佳,施漪雯,吴晓宁,等.影像学诊断技术在非酒精性脂肪性肝病中的应用价值[J].临床肝胆病杂志,2018,34(12):2698-2701. |